MedTrace Logo

Apatinib for the Elderly Advanced Gastric Cancer

NCT03104283 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2022-03-15

No results posted yet for this study

Summary

The purpose of our study is to assess the efficacy and safety of apatinib in elderly advanced gastric cancer patients, and to find the relationship between the expression of VEGFR-2 and efficacy of apatinib treatment.

Conditions

Interventions

DRUG

Apatinib

take apatinib orally until disease progression or appearance of unbearable toxicity

Sponsors & Collaborators

  • Affiliated Hospital of Qinghai University

    lead OTHER

Principal Investigators

  • Jiuda Zhao, M.D. · Affiliated Hospital of Qinghai University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-05
Primary Completion
2019-12-01
Completion
2020-06-02

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03104283 on ClinicalTrials.gov